Vihren Kolev Email

Principal Scientist . METiS Therapeutics

Current Roles

Employees:
38
Revenue:
$3.8M
About
The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism- driven quantum mechanics and molecular dynamics simulations to calculate Active Pharmaceutical Ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical and pharmacokinetic properties of small molecule and nucleic acid therapeutics in specific microenvironments. This enables efficient lead optimization, candidate selection and formulation design. Founded by a team of MIT researchers, serial entrepreneurs and biotech industry veterans, METiS develops and in-licenses novel assets with high therapeutic potential that could benefit from its data-driven platform.
METiS Therapeutics Address
245 Main St
Cambridge, MA
METiS Therapeutics Email

Past Companies

METiS TherapeuticsPrincipal Scientist
Takeda OncologyScientist
VerastemSenior Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.